Cargando…
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
The SARS-CoV-2 Virus (COVID-19) is responsible for over 239 million cases and 4.8 million deaths globally (Data source WHO COVID-19 Dashboard accessed on October 14, 2021). It continues to surge and ravage countries, leaving healthcare systems in constant struggle and uncertainty. A variety of vacci...
Autores principales: | Haq, Hannah N., Khan, Hafiz, Chaudhry, Haroon, Nimmala, Swathi, Demidovich, Joseph, Papudesi, Bhavani Nagendra, Potluri, Sai Deepika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Medical Association. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613973/ https://www.ncbi.nlm.nih.gov/pubmed/36511275 http://dx.doi.org/10.1016/j.jnma.2022.08.003 |
Ejemplares similares
-
Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
por: Xia, Xuhua
Publicado: (2021) -
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
por: Islam, Nazmul, et al.
Publicado: (2022) -
Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech/mRNA-1273: Various toxicities: 13 case reports
Publicado: (2021) -
COVID 19 Vaccine Pfizer BioNTech/mRNA-1273/ravulizumab: Various toxicities: 5 case reports
Publicado: (2021)